Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
A new ad campaign takes aim at the "misaligned incentives" in the No Surprises Act arbitration process, arguing they "create a ‘fox guarding the hen house’ dynamic." | A new seven-figure ad campaign takes aim at the "misaligned incentives" in the No Surprises Act arbitration process, arguing they "create a ‘fox guarding the hen house’ dynamic."
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Doceree launches Daily Command, an AI platform for brand teams co-built by pharma leaders

Integrated CDO capabilities reduce early development complexity

FDA floats possible approach to repurpose approved drugs under new uses

Why big digital health players are missing from Medicare's chronic care experiment

The Regulatory Tsunami No One In Advertising Is Talking About

Targeted Protein Degradation and Novel Modalities: Getting on the Frontline

A Unique Oregon Law Allows It to Block Healthcare Deals. In Five Years, the State Hasn’t Done So Once.

Regulatory tracker: Taiho's Inqovi widens its reach with FDA label expansion

Doctors Skeptical of Insurers' Pledges to Rein in Prior Authorization

Biopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?